Artificial pancreas will be piloted in 1,000 diabetics, says...

NHS England will provide artificial pancreas devices to 1,000 type 1 diabetes patients as part of a pilot study of the technology, according to chief executive Sir Simon Stevens.

Arecor hopes London stock market float will raise profile of...

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced prop

FDA approves Tandem’s connected insulin controller

FDA takes another step to encourage copycat insulin products

Lilly doubles down on Dexcom tech for connected insulin devi...